D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments 5.71M 12.85M 20.76M 30.40M 37.33M
Total Receivables -- 21.40K 55.00K 97.00K 224.90K
Inventory -- -- -- -- --
Prepaid Expenses 3.59M 3.43M 2.98M 2.04M 2.03M
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 9.31M 16.30M 23.79M 32.54M 39.58M

Total Current Assets 9.31M 16.30M 23.79M 32.54M 39.58M
Net Property, Plant & Equipment 20.40M 21.37M 19.92M 20.75M 21.79M
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 417.50K 449.80K 482.10K 514.40K 521.70K
Total Assets 30.13M 38.12M 44.20M 53.80M 61.89M

Total Accounts Payable 2.62M 2.52M 1.69M 1.30M 1.17M
Total Accrued Expenses 7.09M 6.06M 5.47M 6.88M 5.05M
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 963.20K 1.08M 811.80K 524.70K 1.21M
Total Finance Division Other Current Liabilities -- -- -- 114.70K 114.70K
Total Other Current Liabilities -- -- -- 114.70K 114.70K
Total Current Liabilities 10.68M 9.65M 7.98M 8.82M 7.55M

Total Current Liabilities 10.68M 9.65M 7.98M 8.82M 7.55M
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases 5.46M 5.71M 3.86M 4.00M 4.13M
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 1.98M 1.35M 6.39M 4.08M 4.09M
Total Liabilities 18.11M 16.71M 18.23M 16.89M 15.77M

Common Stock & APIC 157.03M 156.41M 155.80M 155.15M 154.10M
Retained Earnings -139.48M -129.37M -124.17M -112.77M -102.42M
Treasury Stock & Other -5.54M -5.63M -5.66M -5.47M -5.55M
Total Common Equity 12.02M 21.41M 25.97M 36.90M 46.12M

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible 0.00 0.00 0.00 0.00 0.00
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity 0.00 0.00 0.00 0.00 0.00

Total Common Equity 12.02M 21.41M 25.97M 36.90M 46.12M
Total Preferred Equity 0.00 0.00 0.00 0.00 0.00
Total Minority Interest -- -- -- -- --
Total Equity 12.02M 21.41M 25.97M 36.90M 46.12M